Clinical Trial Update: A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates LCAR-AIO CAR-T cells for relapsed/refractory neurological autoimmune diseases, recruiting at a major Chinese medical center. Condit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mog Antibody-associated Disease
• Multiple Sclerosis
• Myasthenia Gravis
• Neuromyelitis Optica Spectrum Disorder

Drugs mentioned

• LCAR-AIO CAR-T Cells

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disease (NMOSD) | Phase 1 | Status: RECRUITING